210 related articles for article (PubMed ID: 22348467)
21. Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild-type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF.
Liu Y; Fung S; Gane EJ; Dinh P; Flaherty JF; Svarovskaia ES; Miller MD; Kitrinos KM
J Med Virol; 2014 Sep; 86(9):1473-81. PubMed ID: 24861361
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.
Si-Ahmed SN; Pradat P; Zoutendijk R; Buti M; Mallet V; Cruiziat C; Deterding K; Dumortier J; Bailly F; Esteban R; Wedemeyer H; Janssen HL; Zoulim F
Antiviral Res; 2011 Oct; 92(1):90-5. PubMed ID: 21767570
[TBL] [Abstract][Full Text] [Related]
23. Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
Liaw YF; Sheen IS; Lee CM; Akarca US; Papatheodoridis GV; Suet-Hing Wong F; Chang TT; Horban A; Wang C; Kwan P; Buti M; Prieto M; Berg T; Kitrinos K; Peschell K; Mondou E; Frederick D; Rousseau F; Schiff ER
Hepatology; 2011 Jan; 53(1):62-72. PubMed ID: 21254162
[TBL] [Abstract][Full Text] [Related]
24. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
Yilmaz N; Shiffman ML; Todd Stravitz R; Sterling RK; Luketic VA; Sanyal AJ; Maluf D; Coterell A; Posner MP; Fisher RA
Liver Int; 2008 Jan; 28(1):72-8. PubMed ID: 17983429
[TBL] [Abstract][Full Text] [Related]
26. High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.
Cholongitas E; Papatheodoridis GV
Am J Transplant; 2013 Feb; 13(2):353-62. PubMed ID: 23137006
[TBL] [Abstract][Full Text] [Related]
27. Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.
Saab S; Ham MY; Stone MA; Holt C; Tong M
Liver Transpl; 2009 Apr; 15(4):413-20. PubMed ID: 19326401
[TBL] [Abstract][Full Text] [Related]
28. New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.
Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Papanikolaou V; Akriviadis E
Transpl Int; 2014 Oct; 27(10):1022-8. PubMed ID: 24909714
[TBL] [Abstract][Full Text] [Related]
29. Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal.
Manini MA; Whitehouse G; Bruce M; Passerini M; Lim TY; Carey I; Considine A; Lampertico P; Suddle A; Heaton N; Heneghan M; Agarwal K
Dig Liver Dis; 2018 Sep; 50(9):944-953. PubMed ID: 29735294
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin.
Neff GW; Kemmer N; Kaiser TE; Zacharias VC; Alonzo M; Thomas M; Buell J
Dig Dis Sci; 2007 Oct; 52(10):2497-500. PubMed ID: 17404847
[TBL] [Abstract][Full Text] [Related]
31. A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients.
Manini MA; Bruce M; Whitehouse G; Mazzarelli C; Considine A; Agarwal K; Suddle A; Fagiuoli S; Heaton N; Heneghan M
Transplant Proc; 2021; 53(1):207-214. PubMed ID: 32605776
[TBL] [Abstract][Full Text] [Related]
32. Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
Katz LH; Tur-Kaspa R; Guy DG; Paul M
Cochrane Database Syst Rev; 2010 Jul; (7):CD006005. PubMed ID: 20614442
[TBL] [Abstract][Full Text] [Related]
33. One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantation.
Tanaka T; Renner EL; Selzner N; Therapondos G; Lilly LB
Can J Gastroenterol Hepatol; 2014 Jan; 28(1):41-4. PubMed ID: 24212911
[TBL] [Abstract][Full Text] [Related]
34. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
[TBL] [Abstract][Full Text] [Related]
35. The option of liver transplantation for hepatitis B: where are we?
Samuel D
Dig Liver Dis; 2009 May; 41 Suppl 2():S185-9. PubMed ID: 19482255
[TBL] [Abstract][Full Text] [Related]
36. Prevention of hepatitis B virus reinfection in liver transplant recipients.
Roche B; Samuel D
Intervirology; 2014; 57(3-4):196-201. PubMed ID: 25034488
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.
Schinazi RF; Bassit L; Clayton MM; Sun B; Kohler JJ; Obikhod A; Arzumanyan A; Feitelson MA
Antimicrob Agents Chemother; 2012 Dec; 56(12):6186-91. PubMed ID: 22985879
[TBL] [Abstract][Full Text] [Related]
38. Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.
Katz LH; Paul M; Guy DG; Tur-Kaspa R
Transpl Infect Dis; 2010 Aug; 12(4):292-308. PubMed ID: 20002355
[TBL] [Abstract][Full Text] [Related]
39. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
Dodson SF; de Vera ME; Bonham CA; Geller DA; Rakela J; Fung JJ
Liver Transpl; 2000 Jul; 6(4):434-9. PubMed ID: 10915164
[TBL] [Abstract][Full Text] [Related]
40. [Prevention and management of hepatitis B virus reinfection after liver transplantation].
Ma Y; Tai Q; He XS; Wang GD; Hu AB
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(16):1209-12. PubMed ID: 19781163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]